中国快讯 (China Crunch) 为中国读者提供及时的加密新闻、市场洞察和监管动态。
China’s 3SBio Seeks US$400 Million In Hong Kong To Expand Its Global Drug Pipeline
Chinese biopharmaceutical company 3SBio has launched a major fundraising effort as it aims to strengthen its drug development pipeline and expand its global footprint. The Shenyang-based firm announced plans to raise HK$3.12 billion, or roughly US$401 million, through a new share placement in